DAB2IP and esophageal squamous cell carcinoma: To further investigate whether DAB2IP is capable of modulating the chemoresistance of ESCC cells in vitro, the Kyse150 cell line, which showed the lowest endogenous expression levels of DAB2IP, was subsequently transfected with pcDNA3.1-DAB2IP or the control plasmid pcDNA3.1.